Abstract:Nervous system disorders are prevalent health issues that will only continue to increase in frequency as the population ages. Dying-back axonopathy is a hallmark of many neurologic diseases and leads to axonal disconnection from their targets, which in turn leads to functional impairment. During the course of many of neurologic diseases, axons can regenerate or sprout in an attempt to reconnect with the target and restore synapse function. In amyotrophic lateral sclerosis (ALS), distal motor axons retract from neuromuscular junctions early in the disease-course before significant motor neuron death. There is evidence of compensatory motor axon sprouting and reinnervation of neuromuscular junctions in ALS that is usually quickly overtaken by the disease course. Potential drugs that enhance compensatory sprouting and encourage reinnervation may slow symptom progression and retain muscle function for a longer period of time in ALS and in other diseases that exhibit dying-back axonopathy. There remain many outstanding questions as to the impact of distinct disease-causing mutations on axonal outgrowth and regeneration, especially in regards to motor neurons derived from patient induced pluripotent stem cells. Compartmentalized microfluidic chambers are powerful tools for studying the distal axons of human induced pluripotent stem cells-derived motor neurons, and have recently been used to demonstrate striking regeneration defects in human motor neurons harboring ALS disease-causing mutations. Modeling the human neuromuscular circuit with human induced pluripotent stem cells-derived motor neurons will be critical for developing drugs that enhance axonal regeneration, sprouting, and reinnervation of neuromuscular junctions. In this review we will discuss compensatory axonal sprouting as a potential therapeutic target for ALS, and the use of compartmentalized microfluidic devices to find drugs that enhance regeneration and axonal sprouting of motor axons.

Disruption of axonal transport in neurodegeneration

Research Progress on Vesicular Trafficking in Amyotrophic Lateral Sclerosis.

Common mechanisms underlying axonal transport deficits in neurodegenerative diseases: a mini review

Autophagy in Axonal and Dendritic Degeneration

Axonal Transport and Neurodegeneration: How Marine Drugs Can Be Used for the Development of Therapeutics

Autophagy in axonal and dendritic degeneration.

Mitochondrial transport serves as a mitochondrial quality control strategy in axons: Implications for central nervous system disorders

Regulation of neuronal autophagy and the implications in neurodegenerative diseases

Axon & dendrite degeneration: its mechanisms and protective experimental paradigms.

Transport of Autophagosomes in Neurites of Pc12 Cells During Serum Deprivation

Role of Dynein and Dynactin (DCTN-1) in Neurodegenerative Diseases

Role Of Autophagy In Neurite Degeneration In Vitro

Axonopathy Underlying Amyotrophic Lateral Sclerosis: Unraveling Complex Pathways and Therapeutic Insights

Selective motor activation in organelle transport along axons

The Role of Axon Transport in Neuroprotection and Regeneration

Mitophagy coordination with retrograde transport ensures the integrity of synaptic mitochondria

Pathophysiology of neurodegenerative diseases: An interplay among axonal transport failure, oxidative stress, and inflammation?

Axonal regeneration and sprouting as a potential therapeutic target for nervous system disorders

Endoplasmic reticulum and mitochondria in diseases of motor and sensory neurons: a broken relationship?

Microtubule And Kinesin/Dynein-Dependent, Bi-Directional Transport Of Autolysosomes In Neurites Of Pc12 Cells

NAD+-dependent Mechanism of Pathological Axon Degeneration